Cargando…
Pharmacogenetic association with early response to intravitreal ranibizumab for age-related macular degeneration in a Korean population
PURPOSE: To determine whether genetic factors that influence age-related macular degeneration (AMD) have an early pharmacogenetic effect on treating exudative AMD with ranibizumab in a Korean population. METHODS: A retrospective study of 102 patients (70 with typical neovascular AMD and 32 with poly...
Autores principales: | Chang, Woohyok, Noh, Dong Hyoun, Sagong, Min, Kim, In Taek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Vision
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3611944/ https://www.ncbi.nlm.nih.gov/pubmed/23559864 |
Ejemplares similares
-
Switching from Intravitreal Ranibizumab to Bevacizumab for
Age-Related Macular Degeneration
por: Yamada, Kisaburo, et al.
Publicado: (2011) -
Application of Intravitreal Bevacizumab for Circumscribed Choroidal Hemangioma
por: Sagong, Min, et al.
Publicado: (2009) -
Genetic association with intravitreal ranibizumab response for neovascular age-related macular degeneration in Hispanic population
por: Rodríguez, Francisco Jose, et al.
Publicado: (2019) -
Macular Hole Formation After Intravitreal Ranibizumab Injection in Wet Age-Related Macular Degeneration
por: Mukherjee, Chandoshi, et al.
Publicado: (2015) -
Real-World Effectiveness, Treatment Pattern, and Safety of Ranibizumab in Korean Patients with Neovascular Age-Related Macular Degeneration: Subgroup Analyses from the LUMINOUS Study
por: Sagong, Min, et al.
Publicado: (2021)